Jejunal atresia related to the use of methylene blue in genetic amniocentesis in twins (1992)

Peer-Reviewed Study · van der Pol JG, Wolf H, Boer K, Treffers PE, Leschot NJ, Hey HA, Vos A · February 1992

van der Pol JG, 1992-02: Retrospective Dutch study of 89 consecutive twin pregnancies with amniocentesis (86 using methylene blue to mark the first sac): jejunal atresia occurred in 17 pregnancies (19%) against a national incidence of 1 in 14,000, and in all 15 cases where the exposed twin could be identified it was the exposed infant.

In all 15 pregnancies, the infant exposed to the dye was suffering from jejunal atresia.

van der Pol JG, 1992-02: Retrospective Dutch study of 89 consecutive twin pregnancies with amniocentesis (86 using methylene blue to mark the first sac): jejunal atresia occurred in 17 pregnancies (19%) against a national incidence of 1 in 14,000, and in all 15 cases where the exposed twin could be identified it was the exposed infant. C4 primary report of the fetal intestinal injury. Dose/route: intra-amniotic methylene blue solution injected to mark the sac (concentration not stated in abstract); no light dose. Funder/conflicts not stated in abstract. Comparator: national incidence and the unexposed twin. Authors recommend no dye be injected into the amniotic sac. Also filed as MTF-43 (claims C4, C9). Study type: uncontrolled series.